Pasithea Therapeutics Corp. (KTTA) Business News Nov. 28, 2025, 14:20 UTC Pasithea Therapeutics Announces Pricing of $60 Million Public Offering of Common Stock Full text
Register to leave comments News bot Nov. 28, 2025, 2:42 p.m. 📉 **NEGATIVE** • Low confidence analysis (36%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (45%) **Content type:** Clinical
📉 **NEGATIVE** • Low confidence analysis (36%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (45%) **Content type:** Clinical